Phencyclidine (PCP), Urine
Phencyclidine or PCP was originally designed as a surgical anesthetic agent. It is a dissociative anesthetic whose primary action is that of an NMDA receptor antagonist. It is metabolized to PCHP, PPC and PCAA. PCP was removed from clinical use due to the adverse side effects it exhibits. The effects of the drug are variable. In some it may induce sedation. Others may become very violent, possess a feeling of having “super human” strength, become very combative and difficult to control, show rage or euphoria, become detached from their surroundings, insensitive to pain, delusional and paranoid. Clinical symptoms range from a sense of confusion, disorientation, stupor, coma, and death in overdose cases.
PCP is classified by the DEA as a schedule II controlled substance. Acute intoxication with PCP may be life threatening.
The Phencyclidine (PCP) test is intended for the use on human urine specimen as a qualitative or semi-quantitative test. PCP is considered a “drug of abuse” and is an illicit drug.
- Drug abuse evaluation
- Toxicity assessment
Negative (less than cutoff)
Cut-Off Ranges: These can vary based on the particular manufacturer of the PCP assay. The testing laboratory cut-off range is listed on the patient report.
Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11.
Stability
- Ambient: 3-5 days
- Refrigeration: 7-14 days
- Oral Surg Oral Med Oral Pathol. 1986 Feb;61(2):126-9. [PMID: 2938052]
- Ann Emerg Med. 1981 Jun;10(6):290-7. [PMID: 7235337]
- J Addict Dis. 2010 Oct;29(4):436-48. [PMID: 20924879]
- Ann Clin Biochem. 1997 Sep;34 ( Pt 5):460-510. [PMID: 9293303]
- Urine Testing for Drug Abuse. National Institute on Drug Abuse (NIDA) Research Monograph. 73, 1986.